Survivorship, Version 2.2017: Clinical practice guidelines in oncology

Crystal S. Denlinger; Tara Sanft; K. Scott Baker; Shrujal Baxi; Gregory Broderick; Wendy Demark-Wahnefried; Debra L. Friedman; Mindy Goldman; Melissa Hudson; Nazanin Khakpour; Allison King; Divya Koura; Elizabeth Kvale; Robin M. Lally; Terry S. Langbaum; Michelle Melisko; Jose G. Montoya; Kathi Mooney; Javid J. Moslehi; Tracey O'Connor; Linda Overholser; Electra D. Paskett; Jeffrey Peppercorn; M. Alma Rodriguez; Kathryn J. Ruddy; Paula Silverman; Sophia Smith; Karen L. Syrjala; Amye Tevaarwerk; Susan G. Urba; Mark T. Wakabayashi; Phyllis Zee; Deborah A. Freedman-Cass; Nicole R. McMillian

doi:10.6004/jnccn.2017.0146

Survivorship, Version 2.2017: Clinical practice guidelines in oncology

Crystal S. Denlinger, Tara Sanft, K. Scott Baker, Shrujal Baxi, Gregory Broderick, Wendy Demark-Wahnefried, Debra L. Friedman, Mindy Goldman, Melissa Hudson, Nazanin Khakpour, Allison King, Divya Koura, Elizabeth Kvale, Robin M. Lally, Terry S. Langbaum, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Javid J. Moslehi, Tracey O'ConnorLinda Overholser, Electra D. Paskett, Jeffrey Peppercorn, M. Alma Rodriguez, Kathryn J. Ruddy, Paula Silverman, Sophia Smith, Karen L. Syrjala, Amye Tevaarwerk, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Deborah A. Freedman-Cass, Nicole R. McMillian

Lymphoma-Myeloma

Research output: Contribution to journal › Review article › peer-review

75 Scopus citations

Abstract

Many cancer survivors experience menopausal symptoms, including female survivors taking aromatase inhibitors or with a history of oophorectomy or chemotherapy, and male survivors who received or are receiving androgen-ablative therapies. Sexual dysfunction is also common in cancer survivors. Sexual dysfunction and menopause-related symptoms can increase distress and have a significant negative impact on quality of life. This portion of the NCCN Guidelines for Survivorship provide recommendations for screening, evaluation, and treatment of sexual dysfunction and menopausal symptoms to help healthcare professionals who work with survivors of adult-onset cancer in the posttreatment period.

Original language	English (US)
Pages (from-to)	1140-1163
Number of pages	24
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	15
Issue number	9
DOIs	https://doi.org/10.6004/jnccn.2017.0146
State	Published - Sep 1 2017

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2017.0146

Cite this

Denlinger, C. S., Sanft, T., Baker, K. S., Baxi, S., Broderick, G., Demark-Wahnefried, W., Friedman, D. L., Goldman, M., Hudson, M., Khakpour, N., King, A., Koura, D., Kvale, E., Lally, R. M., Langbaum, T. S., Melisko, M., Montoya, J. G., Mooney, K., Moslehi, J. J., ... McMillian, N. R. (2017). Survivorship, Version 2.2017: Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network, 15(9), 1140-1163. https://doi.org/10.6004/jnccn.2017.0146

Denlinger, CS, Sanft, T, Baker, KS, Baxi, S, Broderick, G, Demark-Wahnefried, W, Friedman, DL, Goldman, M, Hudson, M, Khakpour, N, King, A, Koura, D, Kvale, E, Lally, RM, Langbaum, TS, Melisko, M, Montoya, JG, Mooney, K, Moslehi, JJ, O'Connor, T, Overholser, L, Paskett, ED, Peppercorn, J, Rodriguez, MA, Ruddy, KJ, Silverman, P, Smith, S, Syrjala, KL, Tevaarwerk, A, Urba, SG, Wakabayashi, MT, Zee, P, Freedman-Cass, DA & McMillian, NR 2017, 'Survivorship, Version 2.2017: Clinical practice guidelines in oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 15, no. 9, pp. 1140-1163. https://doi.org/10.6004/jnccn.2017.0146

@article{7bda531fb05c42c594dc10f234f3ab22,

title = "Survivorship, Version 2.2017: Clinical practice guidelines in oncology",

abstract = "Many cancer survivors experience menopausal symptoms, including female survivors taking aromatase inhibitors or with a history of oophorectomy or chemotherapy, and male survivors who received or are receiving androgen-ablative therapies. Sexual dysfunction is also common in cancer survivors. Sexual dysfunction and menopause-related symptoms can increase distress and have a significant negative impact on quality of life. This portion of the NCCN Guidelines for Survivorship provide recommendations for screening, evaluation, and treatment of sexual dysfunction and menopausal symptoms to help healthcare professionals who work with survivors of adult-onset cancer in the posttreatment period.",

author = "Denlinger, {Crystal S.} and Tara Sanft and Baker, {K. Scott} and Shrujal Baxi and Gregory Broderick and Wendy Demark-Wahnefried and Friedman, {Debra L.} and Mindy Goldman and Melissa Hudson and Nazanin Khakpour and Allison King and Divya Koura and Elizabeth Kvale and Lally, {Robin M.} and Langbaum, {Terry S.} and Michelle Melisko and Montoya, {Jose G.} and Kathi Mooney and Moslehi, {Javid J.} and Tracey O'Connor and Linda Overholser and Paskett, {Electra D.} and Jeffrey Peppercorn and Rodriguez, {M. Alma} and Ruddy, {Kathryn J.} and Paula Silverman and Sophia Smith and Syrjala, {Karen L.} and Amye Tevaarwerk and Urba, {Susan G.} and Wakabayashi, {Mark T.} and Phyllis Zee and Freedman-Cass, {Deborah A.} and McMillian, {Nicole R.}",

note = "Publisher Copyright: {\textcopyright} 2017 JNCCN-Journal of the National Comprehensive Cancer Network.",

year = "2017",

month = sep,

day = "1",

doi = "10.6004/jnccn.2017.0146",

language = "English (US)",

volume = "15",

pages = "1140--1163",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "9",

}

TY - JOUR

T1 - Survivorship, Version 2.2017

T2 - Clinical practice guidelines in oncology

AU - Denlinger, Crystal S.

AU - Sanft, Tara

AU - Baker, K. Scott

AU - Baxi, Shrujal

AU - Broderick, Gregory

AU - Demark-Wahnefried, Wendy

AU - Friedman, Debra L.

AU - Goldman, Mindy

AU - Hudson, Melissa

AU - Khakpour, Nazanin

AU - King, Allison

AU - Koura, Divya

AU - Kvale, Elizabeth

AU - Lally, Robin M.

AU - Langbaum, Terry S.

AU - Melisko, Michelle

AU - Montoya, Jose G.

AU - Mooney, Kathi

AU - Moslehi, Javid J.

AU - O'Connor, Tracey

AU - Overholser, Linda

AU - Paskett, Electra D.

AU - Peppercorn, Jeffrey

AU - Rodriguez, M. Alma

AU - Ruddy, Kathryn J.

AU - Silverman, Paula

AU - Smith, Sophia

AU - Syrjala, Karen L.

AU - Tevaarwerk, Amye

AU - Urba, Susan G.

AU - Wakabayashi, Mark T.

AU - Zee, Phyllis

AU - Freedman-Cass, Deborah A.

AU - McMillian, Nicole R.

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Many cancer survivors experience menopausal symptoms, including female survivors taking aromatase inhibitors or with a history of oophorectomy or chemotherapy, and male survivors who received or are receiving androgen-ablative therapies. Sexual dysfunction is also common in cancer survivors. Sexual dysfunction and menopause-related symptoms can increase distress and have a significant negative impact on quality of life. This portion of the NCCN Guidelines for Survivorship provide recommendations for screening, evaluation, and treatment of sexual dysfunction and menopausal symptoms to help healthcare professionals who work with survivors of adult-onset cancer in the posttreatment period.

AB - Many cancer survivors experience menopausal symptoms, including female survivors taking aromatase inhibitors or with a history of oophorectomy or chemotherapy, and male survivors who received or are receiving androgen-ablative therapies. Sexual dysfunction is also common in cancer survivors. Sexual dysfunction and menopause-related symptoms can increase distress and have a significant negative impact on quality of life. This portion of the NCCN Guidelines for Survivorship provide recommendations for screening, evaluation, and treatment of sexual dysfunction and menopausal symptoms to help healthcare professionals who work with survivors of adult-onset cancer in the posttreatment period.

UR - http://www.scopus.com/inward/record.url?scp=85028992405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028992405&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2017.0146

DO - 10.6004/jnccn.2017.0146

M3 - Review article

C2 - 28874599

AN - SCOPUS:85028992405

SN - 1540-1405

VL - 15

SP - 1140

EP - 1163

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 9

ER -

Survivorship, Version 2.2017: Clinical practice guidelines in oncology

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this